Effect of Metamucil on Bowel Preparation for Colonoscopy

ISRCTN ISRCTN76623768
DOI https://doi.org/10.1186/ISRCTN76623768
Secondary identifying numbers N/A
Submission date
09/12/2003
Registration date
10/12/2003
Last edited
29/08/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Marc Basson
Scientific

4646 John R
Detroit
48201
United States of America

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBowel Preparation for Colonoscopy
InterventionPatients randomised to 4 days of Metamucil versus Placebo prior to consuming a standard lavage, followed by colonoscopy
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Metamucil
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2002
Completion date01/01/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants64
Key inclusion criteriaPatients scheduled for colonoscopy using a standard lavage preparation
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2002
Date of final enrolment01/01/2003

Locations

Countries of recruitment

  • United States of America

Study participating centre

4646 John R
Detroit
48201
United States of America

Sponsor information

Procter and Gamble Company (USA)
Industry

P.O. Box 8006
Mason,Ohio
45040
United States of America

ROR logo "ROR" https://ror.org/04dkns738

Funders

Funder type

Industry

Procter and Gamble Company (USA)

No information available

Wayne State University (USA)
Government organisation / Universities (academic only)
Alternative name(s)
Wayne State, WSU
Location
United States of America

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 02/02/2004 Yes No